Oct. 1, 2013
Metamark Genetics, Inc., a leader in the discovery of molecular prognostic and diagnostic tests for cancer, today announced that
Cornelius J. Merlini
, former general manager of HealthTronics Laboratory Solutions (HLS), has been appointed Metamark's Senior Vice President and Chief Commercial Officer. In
, Metamark acquired HLS, a national uropathology laboratory, from Endo Health Solutions, Inc. Mr. Merlini will report to Metamark President and Chief Executive Officer,
Shawn M. Marcell
, and will join the company's senior leadership team.
"We are pleased that Cornelius has joined Metamark. His exceptional leadership, commercial acumen, and track record bringing paradigm-changing products to market have produced transformational business growth," said Mr. Marcell. "Cornelius already is an established leader of Metamark's newly-acquired uropathology business, where he assembled a talented, dedicated team – including a specialized national field sales force. This commercial team nicely complements Metamark's innovative research and development efforts, and will accelerate the launch of ProMark™, our novel prostate cancer prognostic test."
"Metamark's strong science engine fits perfectly with its new commercial and operational machine," said Mr. Merlini. "ProMark™ could redefine the management of early stage prostate cancer and become a standard test sought by patients and ordered by urologists when making well-informed treatment decisions. It is exciting to join a company that could change the way prostate cancer is treated."
Mr. Merlini has over twenty-five years of life science experience across a wide array of functions and businesses. Prior to HealthTronics Lab Solutions, Mr. Merlini was SVP, Commercial Operations at Cord Blood Registry, a market leader in cord blood stem cell banking. He spent ten years with increasing marketing, management and franchise leadership responsibilities at Johnson & Johnson, where he served most recently as Worldwide Vice-President of the cardiovascular franchise for Johnson & Johnson's biopharmaceutical business. Earlier, Mr. Merlini gained successful sales and sales leadership experience with Marion Laboratories (now Sanofi-Aventis).